Citi Upgrades Auxilium Pharmaceuticals (AUXL) to Buy
Tweet
Share
E-mailGet Alerts AUXL Hot Sheet
Price: $36.47 --0%
Rating Summary:
4 Buy, 9 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 9 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Citi upgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Hold to Buy, price target raised from $22 to $25.
For more ratings news on Auxilium Pharmaceuticals click here and for the rating history of Auxilium Pharmaceuticals click here.
Shares of Auxilium Pharmaceuticals closed at $14.51 yesterday.
For more ratings news on Auxilium Pharmaceuticals click here and for the rating history of Auxilium Pharmaceuticals click here.
Shares of Auxilium Pharmaceuticals closed at $14.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
- Freedom Broker Upgrades Walmart (WMT) to Buy
- Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
